The Annual Survey Working Group of the Jurisprudence Subcommittee, Private Equity and Venture Capital Committee, ABA Business Law Section
The Annual Survey Working Group reports annually on judicial decisions involving private equity and venture capital law. The decisions selected for this year’s Annual Survey are the following:
- 1. West Palm Beach Firefighters’ Pension Fund v. Moelis & Co. (Chancery Court Invalidates Common Provisions Contained in a Stockholders’ Agreement)
- 2. Wagner v. BRP Group, Inc. (Chancery Court Finds Blocking Rights Contained in a Stockholders’ Agreement Violate Delaware Law)
- 3. Hyde Park Ventures Fund, III, L.P. v. FairXchange (Chancery Court Finds Deal Price to Be the “Least Bad Method” of Determining the Appraisal Value of a Venture-Backed Company)
- 4. Firefighters’ Pension System of Kansas City Trust v. Foundation Building Materials, Inc. (Chancery Court Denies Motion to Dismiss Breach of Fiduciary Duty and Aiding and Abetting Claims Asserted Against Private Equity Fund, Its Board Designees, and Financial Advisor in Connection with the Sale of a Portfolio Company)
- 5. Luxor Capital Group, L.P. v. Altisource Asset Management Corp. (New York Court Declines to Order Partial Payment of Redemption Price Under Terms of Certificate of Designation)
1. West Palm Beach Firefighters’ Pension Fund v. Moelis & Co. (Chancery Court Invalidates Common Provisions Contained in a Stockholders’ Agreement)
Summary
In West Palm Beach Firefighters’ Pension Fund v. Moelis & Co., the Delaware Court of Chancery held that various provisions contained in a stockholder agreement, which were intended to give Ken Moelis, the founder and largest stockholder (the “Founder”) of Moelis & Co. (“Moelis”), control over Moelis following the company’s initial public offering (the “IPO”), were invalid under section 141(a) of the General Corporation Law of the State of Delaware (the “DGCL”). Under section 141(a) of the DGCL, the board of directors of a Delaware corporation, not stockholders or others, manages the business and affairs of the corporation unless the certificate of incorporation otherwise provides. Following the Moelis decision, the Delaware General Assembly enacted new section 122(18) of the DGCL to give corporate boards clear authority to enter into agreements with the corporation’s stockholders and beneficial owners that may contain the types of provisions that the Moelis court invalidated.
Background
Moelis is an investment bank that went public in 2014. Before Moelis’ shares began trading publicly, it entered into a stockholder agreement (the “Stockholder Agreement”) with the Founder and three of his affiliates. The Court of Chancery characterized the Stockholder Agreement as a “new wave” stockholder agreement that, rather than governing how the stockholder-signatories would vote or otherwise exercise rights attendant to their shares, imposed affirmative obligations and restrictions on Moelis itself.
In particular, the Stockholder Agreement required the Moelis board of directors to obtain the Founder’s prior written consent before taking eighteen enumerated categories of corporate action (the “Pre-Approval Requirements”). The court described the Pre-Approval Requirements as so broad that they required “[the Founder’s] signoff in advance for virtually any action the directors might want to take,” including hiring and firing key officers, amending the governing documents or any material contract, issuing debt or equity above certain thresholds, adopting a stockholder rights plan, annual budget, or business plan, entering into new lines of business, initiating or settling material litigation, paying dividends, and entering into fundamental transactions like mergers, consolidations, recapitalizations, sales of all or substantially all of the assets, liquidation, and dissolution.
The Stockholder Agreement also contained seven Board Composition Provisions (the “Challenged Provisions,” which include the Pre-Approval Requirements).
First, the Board must maintain its size at not more than eleven directors (the “Size Requirement”). Second, the Founder is entitled to name a number of designees equal to a majority of the Board (the “Designation Right”). Third, the Board must nominate the Founder’s designees as candidates for election (the “Nomination Requirement”). Fourth, the Board must recommend that stockholders vote in favor of the Founder’s designees (the “Recommendation Requirement”). The Company must use reasonable efforts to elect and maintain the Founder’s designees as directors to serve (the “Efforts Requirement”). Fifth, the Board must fill any vacancy in a seat occupied by a Founder designee with a new Founder designee (the “Vacancy Requirement”). Finally, the Board must populate any committee with a number of the Founder’s designees proportionate to the number of designees on the full Board (the “Committee Composition Provision”).
While the Founder controlled 96.8 percent of Moelis’s outstanding voting power at the time of its IPO in 2014, he sold down to 40.4 percent by the time of the lawsuit.
In March 2023, a Moelis stockholder who had purchased shares shortly after the 2014 IPO brought suit in the Court of Chancery arguing that the Challenged Provisions violated the DGCL by improperly infringing upon the board’s statutory power to manage the corporation’s business and affairs under section 141(a). The parties cross-moved for summary judgment. In an initial, separate opinion, the Court of Chancery rejected defendants’ equitable defenses of laches and acquiescence, reasoning that void acts (like those resulting from a statutory violation) are not susceptible to equitable cure and that the statutory violations at issue were best viewed as “continuing wrongs” rather than discrete acts for which claims accrued in 2014. The court rejected a ripeness defense under similar logic.
Analysis
The Court of Chancery’s subsequent opinion on the merits found most of the Challenged Provisions to be facially invalid—a result only justified if they “[could not] operate lawfully in the face of section 141(a) under any circumstances.” In concluding that most of the Challenged Provisions met that high bar for facial invalidity, the court created a new, two-part test: first, the court must determine whether the challenged provision constitutes part of an “internal governance arrangement,” and, second, if so, whether the challenged provision violates section 141(a).
In creating the new test, the court surveyed existing precedents that the court found collectively supported a “clear rule” that the court “must first determine whether the challenged provision constitutes part of the corporation’s internal governance arrangement” rather than an “external commercial agreement.” If the latter, the inquiry will end and the facial validity challenge under section 141(a) will fail. If the former, the reviewing court will proceed to the second step of applying the test set forth in Abercrombie v. Davies and ask whether the provision removes “in a very substantial way” directors’ “duty to use their own best judgment on management matters” or “freedom . . . on matters of management policy.” In so holding, the court expressly parted with Sample v. Morgan, which had sponsored “jettisoning section 141(a) review for corporate contracts” as anathema to the boards’ practical need to contract with commercial third parties, on grounds that the new test’s first prong would give courts a way to rationally balance boards’ commercial priorities with their statutory mandate to manage the corporation under section 141(a).
Next, the court offered guidance on how to apply each prong. As for the first, the court listed seven factors suggestive of an internal governance arrangement rather than a commercial contract: (1) “One factor is that governance agreements frequently have a statutory grounding in a section of the DGCL”; (2) “A second factor is that the corporation's counterparties in a governance agreement hold roles as intra-corporate actors”; (3) “A third factor is that the challenged provisions seek to specify the terms on which intra-corporate actors can authorize the corporation's exercise of its corporate power”; (4) “A fourth factor is that, unlike a commercial contract, a governance agreement does not readily reveal an underlying commercial exchange”; (5) “A fifth and related factor is the relationship between the contractual restrictions and a commercial purpose. In a commercial agreement, features that touch on governance seek to protect the underlying transaction”; (6) “A sixth and related factor is the presumptive remedy for breach”; and (7) “A final factor is duration of the contract and the corporation's ability to terminate it.” As for the second prong, the court observed that provisions directly restricting the company or board will generally be invalid, whereas those that merely influence action by imposing adverse consequences may be decided on a case-by-case basis.
Applying the new test, the court held that most of the Challenged Provisions were invalid. First, the court concluded that they were “prototypical governance provisions in a prototypical governance agreement” under each of the seven factors listed above. In particular, the court noted that the Stockholder Agreement was grounded in section 218 of the DGCL, that all counterparties were intra-corporate actors, and that the Challenged Provisions constrained board action, supported no underlying commercial bargain, lacked terminability, and would likely support an injunction remedy rather than money damages.
The court split its assessment of the second prong into two parts. First, the court held that the Pre-Approval Requirements, taken collectively and not individually, violated section 141(a) by imposing direct restrictions on the board’s ability to act. In so holding, the court rejected defendants’ argument that the pre-approval mechanism would operate legitimately where the board and the Founder agreed, on the basis of the court’s finding, that in that scenario “the provisions are not operating at all.” The court further rejected the related argument that the board could operate freely under the Pre-Approval Requirements subject to the sole limitation of a potential veto, reasoning that “the power to review is the power to decide” and that directors’ anticipation of the constraint “results in a present, negative, and detrimental effect” that substantially curtails their authority.
Second, the court analyzed the Board Composition Provisions one by one. It concluded that the Recommendation Requirement, Vacancy Requirement, Size Requirement, and Committee Composition Provision were each invalid because they prevented the board from using “their own best judgment on a management matter”—namely, the size and composition of the board and its committees. By contrast, the Designation Right was valid because it did not require board action, the Nomination Requirement was valid because nominating directors is a right the board shares with stockholders, and the Efforts Requirement was valid because it could operate legitimately to “obligate the Company to take ministerial steps” in furtherance of the Founder nominees’ candidacy.
In holding that most of the Challenge Provisions were invalid, the court rejected Moelis’s arguments regarding the impact of such a holding on market practice and the thousands of agreements that could be invalidated as a result thereof, noting that “market practice is not law.” The court further concluded the opinion by noting that “[w]hen market practice meets a statute, the statute prevails. . . . Of course, the General Assembly could enact a provision stating what stockholder agreements can do. Unless and until it does, the statute controls.”
New Section 122(18)
Following the court’s decision in Moelis, the Delaware General Assembly enacted section 122(18), which expressly authorizes a corporation, notwithstanding section 141(a), to make contracts with one or more current or prospective stockholders (or one or more beneficial owners of stock), in which the corporation may, among other things, agree to:
(a) restrict or prohibit itself from taking actions specified in the contract, (b) require the approval or consent of one or more persons or bodies before the corporation may take actions specified in the contract (which persons or bodies may include the board of directors or one or more current or future directors, stockholders or beneficial owners of stock of the corporation), and (c) covenant that the corporation or one or more persons or bodies will take, or refrain from taking, actions specified in the contract (which persons or bodies may include the board of directors or one or more current or future directors, stockholders or beneficial owners of stock of the corporation).
As explained in the legislative synopsis, section 122(18) provides “bright-line authorization” for the contractual provisions invalided in Moelis. Thus, section 122(18) provides “for a different rule than the portion of the Moelis decision in which the court held that contract provisions of this nature must be included in the certificate of incorporation to be valid.”
Section 122(18) became effective on August 1, 2024, and, subject to a limited exception, applies to all contracts made by a corporation, whether or not the contract was made on or before August 1, 2024. However, section 122(18) does not apply or affect any civil action or proceeding completed or pending on or before August 1, 2024. As such, following August 1, 2024, except with respect to situations in which there is completed or pending litigation, a stockholder agreement that includes one or more permitted covenants is no longer susceptible to challenge on the basis of facial invalidity for violating section 141(a), whether or not the stockholder agreement was entered into before or after August 1, 2024.
Importantly, while section 122(18) authorizes a corporation to enter into stockholder agreements and to include one or more permitted covenants in such agreements, it addresses the statutory validity of such agreements and covenants and does not guaranty their enforceability. Rather, section 122(18) expressly provides that “no provision of such contract shall be enforceable against the corporation to the extent such contract provision is contrary to the certificate of incorporation or would be contrary to the laws of [the State of Delaware] (other than § 115 of [the DGCL]) if included in the certificate of incorporation.” Accordingly, while section 122(18) dispenses with the need to amend the certificate of incorporation in order for a corporation to have the power and authority to agree to a permitted covenant, to the extent that any permitted covenant is contrary to the certificate of incorporation, an amendment to the certificate of incorporation would be necessary to ensure the enforceability of such covenant. Notably, for purposes of applying this limitation on enforceability, section 122(18) specifies that “a restriction, prohibition or covenant in any such contract that relates to any specified action shall not be deemed contrary to the laws of [the State of Delaware] or the certificate of incorporation by reason of a provision of [the DGCL] or the certificate of incorporation that authorizes or empowers the board of directors (or any one or more directors) to take such action.” As explained in the legislative synopsis, a general recitation in the certificate of incorporation of section 141(a) that the business and affairs of the corporation shall be managed by or under the direction of the board of directors of the corporation “would not be sufficient to render inoperable the provisions of section 122(18) because such recitation merely authorizes the board of directors to manage, or direct the management of, the business and affairs of the corporation.”
In addition to the express limitation of enforceability set forth in section 122(18), the entry into a stockholder agreement with one or more permitted covenants does not dispense with the corporate actions required to give effect to such covenants, nor does it “relieve any directors, officers or stockholders of any fiduciary duties they owe to the corporation or its stockholders, including . . . with respect to deciding whether to perform, or cause the corporation to perform or to breach, the contract.” For example, a permitted covenant requiring a corporation to amend its certificate of incorporation under one or more circumstances would still require that such amendment be approved and declared advisable by the board of directors and adopted by the stockholders as required under section 242 of the DGCL. Additionally, as noted above, the decision to take such actions in compliance with the permitted covenant would be subject to any fiduciary duties owed to the corporation and would not relieve the board of directors from making a determination that such action is in the best interests of the corporation and all of its stockholders. Furthermore, under section 122(18), any remedies for a breach or an attempted breach of the stockholder agreement must be imposed upon the corporation, and a stockholders agreement may not impose remedies or other consequences against the directors, in their capacities as such, nor may such an agreement bind or purport to bind the board of directors or individual directors as parties to the agreement.
With respect to remedies for a breach or an attempted breach of a stockholder agreement, the legislative synopsis makes clear that there are circumstances where specific performance of a permitted covenant would be unavailable, such as if performance of a permitted covenant required stockholder approval and such approval is not obtained. With respect to money damages for a breach, the legislative synopsis further notes that enforceability of such a claim “may be subject to equitable review, and related equitable limitations, if the making or performance of the contract constitutes a breach of fiduciary duty.”
Conclusion
Following the Court of Chancery’s decision in Moelis, there were numerous questions raised regarding stockholder agreements, in both the public and private company contexts, including with respect to the validity and enforceability thereof. New section 122(18) clearly grants Delaware corporations the power and authority to enter into such agreements and to agree to one or more permitted covenants. However, the decision to enter into such an agreement, as well as to perform thereunder, remains subject to any fiduciary duties owed to the corporation and its stockholders and corporations. Practitioners should diligently monitor any developments in subsequent cases analyzing stockholder agreements and applying new section 122(18).
2. Wagner v. BRP Group, Inc. (Chancery Court Finds Blocking Rights Contained in a Stockholders’ Agreement Violate Delaware Law)
Summary
In Wagner v. BRP Group, Inc., applying the framework developed in Moelis, the Delaware Court of Chancery found that three approval rights granted to stockholders under a stockholders’ agreement violated section 141(a) of the DGCL, which, at the time of the court’s decision, provided that the directors of a Delaware corporation manage the business and affairs of the corporation unless the corporation’s certificate of incorporation or the DGCL otherwise provides. The court concluded that a stockholder’s approval right with respect to significant decisions regarding senior officers violated section 142 of the DGCL and a stockholder approval right over amendments to the corporation’s certificate of incorporation violated section 242 of the DGCL. After litigation began, the corporation and certain stockholders entered into a consent and defense agreement to mitigate the effects of the approval rights (the “Consent Agreement”), which the court found cured the section 141(a) violations but not the section 142 or 242 violations. This decision was rendered prior to the effectiveness of new section 122(18) of the DGCL.
Background
In 2011, Lowry Baldwin, his son, and two other partners co-founded an insurance company, Baldwin Risk Partners, L.L.C. (the “LLC”). Lowry owned a majority of the LLC’s equity through Baldwin Insurance Group Holdings, LLC (“Holdings”). In 2019, Lowry and all of the other equity holders in the LLC (collectively, the “Holders”) prepared to sell equity to the public through an IPO. In connection with the IPO process, the Holders formed BRP Group, Inc. as the publicly listed IPO vehicle and entered into a stockholders’ agreement with BRP (the “Stockholders Agreement”), which required the Holders’ consent before BRP could take significant corporate actions to ensure that Holdings maintained control over BRP post-IPO.
Specifically, the Stockholders Agreement provided that BRP or the LLC could not take specified actions “without first receiving the approval of the Holders holding a majority of the shares of Class B Common Stock held by the Holders [(the “Holder Majority”)].” Specifically, without the consent of the Holder Majority, neither BRP nor the LLC could (i) hire, fire or otherwise replace, or make certain decisions with respect to the compensation and benefits of certain key executive officers (the “Officer Pre-Approval Requirement”); (ii) amend BRP’s certificate of incorporation (the “Charter Pre-Approval Requirement”); or (iii) acquire or dispose of 5 percent or more of BRP’s total assets (the “Transaction Pre-Approval Requirement” and, collectively, with the Officer Pre-Approval Requirement and the Charter Pre-Approval Requirement, the “Pre-Approval Requirements”). Certain Holders and Mr. Baldwin entered into a separate agreement whereby such Holders agreed to vote as Mr. Baldwin directed. Mr. Baldwin “therefore control[led] the exercise of the Pre-Approval Requirements [under the Stockholders Agreement].”
After plaintiff brought the present action challenging the Pre-Approval Requirements, BRP and Holdings entered into the Consent Agreement. Pursuant to the Consent Agreement, Holdings granted its and the other Holders’ irrevocable consent to matters requiring the Holders’ approval under the Stockholder Agreement if a committee of the independent members of BRP’s board unanimously determined in good faith that such matter was in the best interests of BRP and its stockholders.
In this decision, the court ruled on the parties’ cross-motions for summary judgment on the pleadings. The court granted plaintiff ’s motion in part, finding that the Officer Pre-Approval Requirement and the Charter Amendment Pre-Approval Requirement were facially invalid under sections 142 and 242, respectively, of the DGCL, and noted that, without the Consent Agreement, each Pre-Approval Requirement would have been facially invalid under section 141(a) of the DGCL.
Analysis
First, the court rejected BRP’s equitable defenses of laches, waiver, acquiescence, and estoppel. The court rejected a related argument that the Pre-Approval Requirements were voidable in equity, as opposed to void under Grimes v. Donald (Grimes I). In so finding, the court reiterated Delaware’s position that violations of the DGCL are void, rather than voidable, acts, and equity cannot render void acts valid. Second, the court denied BRP’s claim that the Consent Agreement rendered plaintiff ’s claims moot. Specifically, BRP argued that Lowry waived his right to invoke any of the Pre-Approval Requirements if the independent committee unanimously determined in good faith that an action was in the best interests of BRP and its stockholders. According to the court, the Consent Agreement modified rather than eliminated the Holders’ ability to invoke the Pre-Approval Requirements.
Third, the court evaluated plaintiff ’s facial challenges to the Pre-Approval Requirements using the standard the court developed in Moelis. Moelis requires a court to assess whether a contractual restriction on the authority of a board of directors violates section 141(a) of the DGCL by, first, asking whether “the challenged provision appears in a governance arrangement addressing internal affairs issues.” If so, a court then asks whether the provisions “have the ‘effect of removing from directors in a very substantial way their duty to use their own best judgment on management matters’ or ‘tend[] to limit in a substantial way the freedom of directors’ decisions on matters of management policy.’”
On the first Moelis inquiry, the court described the Stockholders Agreement as a “paradigmatic governance agreement.” In Moelis, the court discerned seven considerations that guided the court’s analysis in finding that a stockholders’ agreement constituted part of a corporation’s governance arrangement. Although the Wagner court concluded that the Moelis stockholders’ agreement “closely resemble[d]” the Stockholders Agreement, the court still applied each of the seven Moelis considerations to the Stockholders Agreement in support of its conclusion. Specifically, the court observed that (i) the Pre-Approval Requirements were in a stockholders’ agreement authorized by section 218 of the DGCL; (ii) BRP and its pre-IPO owners, including some holding intra-corporate roles, were parties to the Stockholders Agreement; (iii) Mr. Baldwin’s approval was required before BRP could exercise its authority over certain significant internal corporate matters; (iv) the Pre-Approval Requirements were akin to class voting rights that would be granted in a charter or to a class or series of preferred stock; (v) the Stockholders Agreement centered around control rights rather than evidencing a commercial exchange; (vi) BRP was unable to terminate the Stockholders Agreement so long as the Holders owned a minimum percentage of BRP’s equity; and (vii) the Pre-Approval Requirements were control rights likely to be enforced through injunctive relief.
The court also found that each of the Pre-Approval Requirements, on an individual basis, failed the second Moelis inquiry and, because they were not contained in the certificate of incorporation, were facially invalid under section 141(a) of the DGCL. With respect to the Officer Pre-Approval Requirement, the court emphasized that one of the most important decisions a board can make is to hire, monitor, and fire the CEO, and described any significant decision regarding senior officers as a “core management matter.” The court rejected BRP’s argument that this restriction on the board’s authority was merely a consent right—Mr. Baldwin’s “expansive power to pre-review” the board’s decisions with respect to hiring and firing BRP’s key officers “g[ave] him the power to decide.” As to the Charter Pre-Approval Requirement, the court viewed the DGCL as establishing the board as “the gatekeeper for charter amendments,” and the Board’s “authority over that topic [as] a matter of management policy.” The Charter Pre-Approval Requirement swapped the board for Mr. Baldwin as a gatekeeper over charter amendments, preventing the board from acting to amend the certificate of incorporation without Mr. Baldwin’s consent. Finally, the court viewed the Transaction Pre-Approval Requirement as permitting Mr. Baldwin to decide “whether BRP w[ould] engage in a broad range of material transactions, neutering the traditional prerogative of the Board to make those decisions.”
The court rejected BRP’s arguments that the Stockholders Agreement did not impose a real restriction on the board’s ability to exercise its decision-making authority. The court found that BRP would not have any “meaningful way to defeat the exercise of the Pre-Approval Requirements [under the Stockholders Agreement], including the Officer Pre-Approval Requirement.” In support of this conclusion, the court considered factors bearing on the strong likelihood that the Holders would be able to enforce the terms of the Stockholders Agreement, specifically noting the possibility of injunctive relief, the availability of other remedies to the Holders in the event of an efficient breach of the Stockholders Agreement and the effect of a severability clause in supporting the Stockholders Agreement’s enforceability, and the low likelihood that the board would be able to successfully invoke its fiduciary duties, either generally or at the time of contracting, the implied covenant of good faith, or the fiduciary duties (if any) of Mr. Baldwin as a means of escaping the Stockholders Agreement. In the course of this discussion, the court noted that the Holders’ blocking rights likely could be replicated through a “golden share of preferred stock” but cautioned that such rights, even if housed in a charter, could still be unenforceable, as charter provisions may not “override mandatory features of the DGCL.”
In addition to the section 141(a) violations, the court found that the Officer Pre-Approval Requirement violated sections 142(b) and 142(e) of the DGCL, which permit the charter or bylaws of a corporation to establish the manner in which officers will be selected and how vacancies will be filled. The court noted that “neither the Charter nor the Bylaws authorize[d] the Officer Pre-Approval Requirement,” and section 142 does not authorize a stockholders’ agreement to include the sort of restrictions imposed by the Officer Pre-Approval Requirement. Because the Charter Pre-Approval Requirement circumvented section 242’s process for charter amendments, the court found the Charter Pre-Approval Requirement to be invalid under section 242 of the DGCL.
Finally, the court found that the Consent Agreement enabled the independent committee “to override the Pre-Approval Requirements [under the Stockholders Agreement]” and “sufficiently free[d] the Board to make substantive decisions on matters otherwise governed by [such] Pre-Approval Requirements,” which cured the section 141(a), but not the section 142 or 242, violations. The Consent Agreement did not introduce other decisionmakers into the independent committee’s process, and the independent committee members were empowered to determine the best interests of the stockholders through a subjective good faith lens, the court observed. While the independent committee’s acts were subject to unanimous quorum and voting standards, the court distinguished such procedural limitations from substantive limitations on a board’s authority, noting that procedural limitations do not affect the section 141(a) analysis.
Conclusion
On August 1, 2024, after the court decided Wagner, amendments to the DGCL took effect, which, among other things, responded to Moelis. The Moelis-related amendments (the “Moelis Amendments”) apply retroactively and permit a stockholders’ agreement to restrict a board’s authority to the same extent as would be permissible in a charter. In a post-Moelis Amendment landscape, the court’s distinction between a charter and stockholders’ agreement for section 141(a) purposes is no longer applicable. Regardless, Wagner cautions that even if a restriction on a board’s authority placed in a charter, or, post-Moelis Amendment, in a stockholders’ agreement, passes muster under section 141(a), such restriction may still be invalid under other provisions of the DGCL. Practitioners should carefully review the drafting of stockholder control or blocking rights included in documents that could be construed as part of a corporation’s governance arrangement not just for compliance with section 141(a) of the DGCL but also other DGCL provisions.